Magellan LeadCare II User manual

®
Quick Reference Guide
Note: For use with Analyzer Firmware Version 1.09 or higher.
Please check the label on the bottom of your analyzer
to determine rmware version.

2
• The LeadCare II Blood Lead Analyzer is a CLIA-waived device. Facilities that
perform tests with the LeadCare II System must have a CLIA Certicate of
Waiver as issued under the authority of the Public Health Service Act (PHSA)
(42 U.S.C. 263(a). In addition to a waiver certicate, laboratories performing this
test must comply with all applicable state and local laws.
• Any modications by the laboratory to the test system or the manufacturer’s
instructions will result in the test no longer meeting the requirements of the
waived category.
• All laboratories eligible for a CLIA Certicate of Waiver must follow the manu-
facturer's instructions as specied in the LeadCare II User's Guide, LeadCare II
Quick Reference Guide and LeadCare II Test Kit Package Insert.
• Observe universal precautions for handling blood samples as dened by the
U.S. Public Health Service, Centers for Disease Control. Refer to the LeadCare II
User's Guide for information about where to nd this document.
• The LeadCare treatment reagent contains dilute hydrochloric acid solution
which may cause eye, skin, and respiratory system irritation. In case of acci-
dental contact immediately ush skin and eyes with running water for up to 15
minutes and move to fresh air. Seek medical assistance in situations where eye
contact; skin irritation or burn; or difculty breathing occurs.
• Do NOT mix components from different lots of test kits.
• Test kit components (kit box, sensors, controls, and treatment reagent tubes)
are labeled with expiration dates. Using any item with an expired date may
produce inaccurate results. Do not use any component with an expiration date
that has passed. Check the expiration on the kit box as this is the earliest date.
• Proper sample preparation is essential for accurate results. Take precautions to
ensure that the sample collection area is not contaminated by environmental
sources of lead. Refer to Collecting and Handling Blood Lead Samples—2004
published by the Department of Health and Human Services, Centers for
Disease Control.
• Use only fresh, whole blood. Mix the blood with treatment reagent within 24
hours of collection. Follow sample collection instructions exactly.
Wear protective gloves,
safety glasses and lab
coats.
Dispose of materials in
appropriate biohazard
containers.
Allow analyzer, test kit
and samples to reach
room temperature
before testing.
Precautions
Precautions
Caution
!
P P P
15°C
27°C

3
Analyzer Kit Contents
Calibration Button Reader
LeadCare II Blood
Lead Analyzer
AC Adapter and Plug Set
LeadCare II Flash Drive
containing User’s Guide
& Instructional Videos
(not pictured)
Quick Reference Guide
AA Batteries
Test Kit Contents
Droppers
Treatment Reagent Tubes
Capillary Tubes and Plungers
Calibration Button
Control Solutions
Blood Lead Sensors
Labels
Package Insert
LeadCare II Worksheet &
Assay Control Sheet
Power on the Analyzer
Connect the analyzer to
an outlet using the AC
power cord or install
batteries as shown below.
To turn ON the analyzer,
move the switch to the
left.
To turn the analyzer OFF,
move the switch to the
right.
Battery Installation (Optional)
Insert batteries as shown and replace cover.
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
NAME
PAT ID
POWER
I
POWER
IOIOI
I
3
1
2
4
+
+ -
-
++
--
++
-
+
+ -
-
-
POWER IOIOI
I
1
2
2
POWER
I
POWER
I
Push white tab up and pull blue cover off.
Required Materials
Required
Materials

4
LeadCare II
Record Result
&
Remove Sensor Immediately
PLEASE CALIBRATE
ANALYZER WITH BUTTON
The rst time you turn on
the analyzer, you will see
the PLEASE CALIBRATE
message.
Remove the calibration
button from the test kit.
Analyzer Calibration and Quality Control
Perform this calibration procedure each time you open a new test kit.
1 2
LeadCare II
Record Result
&
Remove Sensor Immediately
IF NEW LOT
TEST CONTROLS
4
LeadCare II
Record Result
&
Remove Sensor Immediately
CALIBRATION
SUCCESSFUL
3
LeadCare II
Record Result
&
Remove Sensor Immediately
PREPARE SAMPLE
US E S ENS OR LOT 001 8A
OR RECALIBRATE
THEN INSERT SENSOR
5
Test two levels of quality
control on each new kit
lot. Refer to the ‘Quality
Control’ section for further
instructions on when to
run controls.
Make sure the number on
the button matches the
display.
The analyzer is ready
when the PREPARE SAMPLE
message appears.
Hold the calibration button
to the button reader until
you hear a beep.
NOTE: Button must touch
both the center contact
and metal side of button
reader.
Quality Control
LeadCare II Blood Lead controls are intended to monitor the accuracy and
precision of your blood lead testing using the LeadCare II Blood Lead Testing System.
How Often to Test with Controls
Test two levels of quality control:1
• on each new lot, or on each new shipment of materials
• with each new operator
• monthly, as a check on continued storage condition
• when problems (storage, operator, instrument, or other) are suspected
or identied
• if required by your laboratory’s standard QC procedure
Results obtained on control samples that are within the expected ranges means
that your LeadCare II System is operating properly. Refer to the LeadCare II User’s
Guide for additional important information on quality control.
Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for
Manufacturers of in Vitro Diagnostic Devices, Guidance for Industry and FDA Staff:, p. 34, viewed 17 August 2017,
<https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/
ucm070890.pdf>.

5
Analyze the control sample according to the instructions provided in the Analyze
the Sample section. Repeat this process for the Level 2 control.
Lead Control Test Results: Expected Results
Control target values and acceptable ranges are provided on the control vial label.
The blood lead result you obtain for a control should be within the acceptable range.
If the results are not within the listed range, refer to the Troubleshooting section
of the User’s Guide. If, after following the instructions, the controls are still out of
range, call Product Support.
CAUTION: Do NOT proceed to patient samples unless both Level 1 and Level 2
control results are within the acceptable ranges.
Using the Controls (See Prepare the Sample for Additional Information)
Treat the controls as you would a patient blood sample. Refer to the LeadCare II
User’s Guide for detailed instructions on how to perform blood lead testing.
Wipe the outside of the
capillary tube to remove
any excess control.
Inspect the capillary tube
to conrm that it is properly
lled (see step 5 on page 7).
Place the capillary tube
into the treatment reagent
tube. Insert a plunger into
the top of the capillary tube
and push down, ensuring
the entire volume of control
is dispensed into the
treatment reagent.
Replace the tube cap. Invert
the tube 8 to 10 times to
mix the sample completely.
Control material in treatment
reagent tube will appear
red.
Label a fresh treatment
reagent tube “Level 1
Control”.
After thorough mixing,
remove the cap from the
Level 1 control vial and
place it top down on a
clean surface.
Holding the capillary tube
almost horizontally with
the green band on top, ll
the tube to the 50 µL black
line. Replace the cap on
the control vial.
13
4 5 6
Calibration &
Quality Control
2

6
3
Label the tube with the patient ID
using the labels provided.
Holding the capillary tube almost
horizontally with the green band
on top, ll the capillary to the 50 µL
black line.
Note: The CDC’s Steps for Collecting Fin-
gerstick Blood Samples for Lead Testing
is provided in Appendix C of the User’s
Guide (see LeadCare II Flash Drive).
If using blood from a microcollection
tube, make sure the blood is well
mixed by inverting the tube 8 to 10
times before sampling.
Hold the capillary tube almost hori-
zontally with the green band on top,
ll the tube to the 50 µL black line.
Do NOT use venous blood samples.
Remove excess blood from the
outside of the tube with a clean
wipe or gauze.
Use caution not to drain the blood
from the end of the capillary tube.
Prepare the Sample
OR
1 2
4

7
Replace the tube cap. Invert the
tube 8 to 10 times to mix the sample
completely.
NOTE: The mixture of blood and
treatment reagent is stable for up
to 48 hours at room temperature
and up to 7 days refrigerated.
If refrigerated, bring to room
temperature prior to analysis.
The sample is ready when the mixture
turns brown. Samples may be stored
up to one week if refrigerated.
CAUTION: Any visual impairment,
such as color blindness may affect
the operator’s ability to detect the
sample color change. Operators with
vision deciencies should invert the
tube 8 to 10 times to ensure that the
sample is properly mixed.
Inspect the capillary tube for proper
lling. Make sure there are no gaps,
air bubbles, or any excess blood on
the outside of the capillary.
Place the capillary tube into the
treatment reagent tube. Insert a
plunger into the top of the capillary
tube and push down, ensuring the
entire volume of sample is dispensed
into the treatment reagent.
5
Correct
Wrong
Under lled
Wrong
Air
Bubbles
Wrong
Excess
Blood
6
7 8
Prepare
the Sample

8
LeadCare II
Record Result
&
Remove Sensor Immediately
Analyze the Sample
Remove a sensor from the sensor
container. Close the container.
Insert the sensor (with black bars
facing up) under the sensor guides
on the sensor deck. Insert completely
into the analyzer until you hear a beep.
Make sure the sensor lot number
matches the display.
Make sure the sample is thoroughly
mixed. Allow samples that were
stored refrigerated to reach room
temperature before use.
Remove the cap from the treatment
reagent tube. Squeeze the walls of
the dropper and insert into the sample.
Release the pressure to draw some
sample into the dropper.
Touch the dropper tip to the Xon
the sensor and squeeze the walls to
dispense the sample. The analyzer
will “beep” and begin the 3 minute
countdown.
12
LeadCare II
Record Result
&
Remove Sensor Immediately
ADD SAMPLE
TO X O N S ENSOR
SENS O R LOT 0 018A
3 4
5
LeadCare II
Record Result
&
Remo
ve Sensor Immediately
ely
6

9
Wait 3 minutes until the test is done.
The analyzer will beep and display
the lead result in µg/dL Pb.
Record the test results on the
LeadCare II worksheet provided.
Remove the used sensor immedi-
ately after recording the test result.
Discard materials in appropriate
containers.
The analyzer is ready for the next
sample.
LeadCare II
Record Result
&
Remove Sensor Immediately
RECO RD T ES T RESULT
7.5 µg/dL Pb
THEN REMOVE SENSOR
SENSOR LOT 0018A
7 8
LeadCare II
Record Result
&
Remove Sensor Immediately
LAST TEST RESULT
7.5 µg/dL Pb
INSERT SENSOR
SENSOR LOT #0018A
9 10
LeadCare II
Record Result
&
Remove Sensor Immediately
RECORD TEST RESULT
7.5 µg/dL Pb
PLEASE REMOVE SENSOR
IMMEDIATELY
11
LeadCare II
Record Result
&
Remove Sensor Immediately
LAST TEST RESULT
7.5 µg/dL Pb
INSERT SENSOR
SENSOR LOT 0018A
12
Analyze
the Sample
A beep will sound if you do not remove
the sensor after the result is displayed.
Once the sensor is removed, the beep
will stop.

10
2CDC (Centers for Disease Control). ‘What Do Parents Need to Know to Protect Their Children?’, 18 May
2012. Web. 26 Sept. 2012, www.cdc.gov/nceh/lead/ACCLPP/blood_lead_levels.htm.
3Newman, N., et al. PEHSU Lead Working Group, June 2013. Recommendations on Medical Management
of Childhood Lead Exposure and Poisoning. Retreived from: http://www.pehsu.net/_Library/facts/medi-
cal-mgmnt-childhood-lead-exposure-June-2013.pdf.
Interpreting Patient Test Results
The analyzer’s display window shows the blood lead result. The result is in micrograms
(µg) of lead per deciliter (dL) of whole blood. No calculation is needed. Results are
displayed to one decimal place. The reportable range of the test is 3.3 to 65 µg/dL.
“Low” in the display window indicates a blood lead test result less than 3.3 µg/dL.
When this occurs, report the blood lead result as less than (<) 3.3 µg/dL.
Interpreting Patient Test Results
“High” in the display windows indicates a blood lead test result greater than
65 µg/dL. When this occurs, report the blood lead result as greater than
(>) 65 µg/dL. “High” results on LeadCare II should be followed up immediately
as an emergency laboratory test.
Blood lead test results should be shared with the patient’s physician for interpretation
and to determine when retesting and follow-up care are necessary.
In 2012, the Centers for Disease Control & Prevention (CDC) established 5 µg/dL as
the new “reference level” for lead in blood, a change from the previously utilized
“level of concern” of 10 µg/dL.2
Repeat Testing Guidelines3
If blood lead level Child’s age* Perform re-test
(capillary sample allowed) within
<5 µg/dL < 12 months 3 - 6 months
1 - 5 years 6 - 12 months
If blood lead level Child’s age* Perform diagnostic test
on venous blood within
5 - 14 µg/dL 1 - 5 years 1 - 3 months
15 - 44 µg/dL 1 - 5 years 1 - 4 weeks
>44 µg/dL 1 - 5 years 48 hours
* Ensure blood lead levels are checked at both 1 and 2 years of age.
Capillary blood samples that generate an elevated lead level should be
conrmed with a venous sample. Venous samples should be sent to a reference
laboratory for conrmation.
In cases where the capillary specimen demonstrates an elevated lead level but
the conrmation venous sample does not, it is important to recognize that the
child may live in a lead-contaminated environment that resulted in contamination
of the ngertip. Efforts should be made to identify and eliminate the source of lead
in these cases.3
Consult your local public health department, or the CDC, for further information on
actions to be taken for blood lead results that are greater than 5 µg/dL.
Report all blood lead test results to the appropriate state or federal agency.